Surgical Drainage Devices Market Applications, Outlook, SWOT Analysis And Forecasts By 2032

 Global Surgical Drainage Devices Market was valued at US$ 1.3 Bililon in 2021 and is expected to reach US$ 2.9 Billion by 2032, finds Future Market Insights (FMI) in a recent market survey. The market growth for Active Drains is projected to expand at a CAGR of around 7.8% during 2022 – 2032. The value of the Active Drains Market increased at a CAGR of around 6.7% during 2017 – 2021.  

Active drains are systems that collect fluid and deposit it in reservoirs. These reservoirs reduce hospital workers' exposure to contaminated fluid. Active drains use an artificial pressure gradient to remove fluid from a wound or body cavity.

To learn more about this report @ https://www.futuremarketinsights.com/reports/surgical-drainage-devices-market

According to the National Library of Medicine, patients with active drains experienced 6% delayed healing compared to 54% for those with passive drains.

Active drains play an important role in improving the outcome of cardiothoracic surgeries, especially in children. As a result, the use of active surgical drain devices among a wide range of end-users has increased along with an increase in the prevalence of chronic diseases like arthritis and osteoporosis. This appears to be primarily driven by significant progress in the medical device industry.

Impact of Covid-19 on the Surgical Drainage Devices Market

The pandemic disrupted routine hospital services all over the world. For patient safety, the hospital reduces the number of elective surgeries during the pandemic. Reduced elective surgery protected patients from viral transmission, but it reduced global demand for Surgical Drainage Devices. According to a British journal of surgery report, over 20 million elective surgeries were canceled during the pandemic.

Wound drainage systems are medical devices that are used to remove fluids, such as blood or pus, from a surgical site or wound. They are commonly used after surgical procedures, including orthopedic surgery, plastic surgery, and general surgery, to prevent the buildup of fluid and reduce the risk of infection.

Competitive Landscape

Some of the key players in Surgical Drainage Devices include Acelity, Teleflex Incorporated, Cardinal Health, Medtronic, Cook Medical, Johnson and Johnson, B. Braun Melsungen AG, Smith & Nephew plc, Stryker, Becton Dickinson, Centese.

Some of the recent developments of key surgical drains devices providers are as follows:

  • In October 2021, Centese created a self-cleaning chest tube device that offers more accurate measurements for keeping tabs on patients recuperating from heart or lung surgery. The device developed by Centese is called the Thoraguard device. This device will help Centese accelerate its growth in the segment of surgical drainage devices.
  • In April 2019, Smith & Nephew plc announced the acquisition of Osiris Therapeutics, Inc. This addition will further accelerate the growth of Smith & Nephew’s surgical drains business and advance the wound care franchise.
  • In October 2019, 3M announced the acquisition of Acelity, Inc.

Surgical Drainage Devices Market Segmentation

By Product Type:

  • Active drains
  • Passive drains

By Application:

  • Thoracic and Cardiovascular Surgeries
  • Neurosurgical Procedures
  • Abdominal Surgery
  • Orthopedics
  • Other Applications

By End-Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Primary Sclerosing Cholangitis (PSC) Market Size, Opportunities and Forecast 2023-2033

Image
  The global Primary Sclerosing Cholangitis (PSC) Market is anticipated to be worth US$ 151.07 million in 2023.  Primary Sclerosing Cholangitis (PSC) With growing alcohol consumption, the worldwide market for Primary Sclerosing Cholangitis (PSC) is expected to develop at a CAGR of 7.6% between 2023 and 2033, totaling roughly US$ 314.26 Million by 2033. According to the analysis of Future Market Insights, the Primary Sclerosing Cholangitis (PSC) market is expected to fuel over the analysis period, attributed to the factors such as the rise in the incidences of liver diseases, as well as rise in alcohol consumption. Get Full Access @ https://www.futuremarketinsights.com/reports/primary-sclerosing-cholangitis-psc-market  As per the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. As per the World Health Organization (WHO), prevalence of liver cirrhosis is increasing in the European countries, due to high con...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more